Trials / Unknown
UnknownNCT03990636
Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial
Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - A Phase 2 Randomized Double-blind Placebo Controlled Clinical Trial
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Instituto Nacional de Cancer, Brazil · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Brazil is a tropical country, with high incidence of ultraviolet radiation throughout the year. Many Europeans migrated to Brazil escaping either war or economic crisis to live in the country searching for opportunities. Low phototype combined with high incidence of UV light is a combination that not only affect the skin but also the lips. The current study was designed to use photodynamic therapy with metil 5-aminolevulinate for actinic cheilitis in a phase 2 clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metil 5-aminolevulinate | Scrubbing lip vermillion and applying the medication or placebo that is activated (or not, in case of placebo) with red light. |
Timeline
- Start date
- 2019-10-17
- Primary completion
- 2020-05-15
- Completion
- 2021-12-15
- First posted
- 2019-06-19
- Last updated
- 2019-06-19
Source: ClinicalTrials.gov record NCT03990636. Inclusion in this directory is not an endorsement.